Mifamurtide receives positive opinion in Europe.

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1666, 2008-01, pp. : 22-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ambrisentan receives positive opinion for approval in the EU.

Inpharma, Vol. 1, Iss. 1627, 2008-01 ,pp. : 19-19

Adis International

Access to resources Recommend Favorite

Not so NICE for mifamurtide

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 608, 2010-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Mifamurtide for the treatment of nonmetastatic osteosarcoma

By Ando Kosei Mori Kanji Corradini Nedège Redini Françoise Heymann Dominique

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 2, 2011-02 ,pp. : 285-292

Informa Healthcare

Access to resources Recommend Favorite

Mifamurtide boosts chemo efficacy in osteosarcoma

Inpharma, Vol. 1, Iss. 1626, 2008-01 ,pp. : 7-7

Adis International

Access to resources Recommend Favorite

Rosuvastatin [Crestor; AstraZeneca] has received a positive opinion in Japan

Inpharma, Vol. 1, Iss. 1467, 2004-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite